Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Article in English | IMSEAR | ID: sea-43772

ABSTRACT

BACKGROUND: As there are considerable variations in normal values of peak expiratory flow rate (PEFR) shown by studies from various population, a study is required to obtain normal values of PEFR in Thai children. OBJECTIVE: To determine the values of PEFR of students in Bangkok. METHODS: In a cross sectional study of PEFR measured with standard Wright peak flow meter, 501 normal students, aged 5 to 15 years, from five public schools in Bangkok were investigated. In the selection process of subjects, strict criteria of "normality" were applied and included history of medical illnesses, physical examination and nutritional status. RESULTS: The relationship between PEFR and height was approximately linear in both male and female children. Prediction equations for each sex were: Male children: PEFR (L/min) = [3.52 x Height (cm)] - 186.80 Female children: PEFR (L/min) = [3.48 x Height (cm)] - 204.11 The PEFR values of students in this study were different from the predicted values of PEFR in those of previous reports in Thai children. These discrepancies might be explained by a variety of study population and environmental factors. CONCLUSIONS: The relationship between PEFR and height of students in Bangkok is best described by a regression equation. The prediction graphs for each sex may be used to monitor PEFR values of children with obstructive airway diseases and to compare an individual's PEFR with those of others of the same height and sex.


Subject(s)
Adolescent , Child , Cross-Sectional Studies , Female , Humans , Male , Peak Expiratory Flow Rate , Reference Values , Thailand
2.
Asian Pac J Allergy Immunol ; 1999 Jun; 17(2): 63-7
Article in English | IMSEAR | ID: sea-37155

ABSTRACT

Bronchial asthma is now agreed as being a chronic inflammatory disease of the airways. Inhaled steroids are widely accepted as a preventive medication in asthmatic patients of all ages and severity. However, the optimal use of inhaled steroids and the important issue of safety and efficacy still remain of concern, particularly in children. Recently, fluticasone propionate (FP) has been developed for use as an inhaled preparation for the treatment of asthma. Because of its high topical potency and increased lipophilicity, it is claimed that FP has an improved risk/benefit compared with other inhaled steroids. In order to evaluate the use of FP in children, we have studied the efficacy of high dose FP (500 microg/day) in asthmatic children. Thirteen children (9 boys and 4 girls), aged 7-17 years (10.8 +/- 2.6), were instructed to use a pressurized metered-dose inhaler connected to a Volumetric spacer. The standard methacholine bronchial challenge test was used as a principal outcome parameter. The PD20, a cumulative dose of methacholine inducing a 20% decrease in FEV1, was measured pre- and post-treatment with inhaled FP. After 4 weeks of FP, PD20 significantly increased from 21.6 +/- 14.3 inhalation unit to 106.6 +/- 78.5 inhalation unit (4.9 fold, p = 0.004) reflecting the improvement of airway reactivity. All subjects improved clinically. These results demonstrate that the anti-inflammatory action of FP 500 microg a day for four weeks can markedly reduce bronchial hyperresponsiveness, the basic physiologic abnormality in bronchial asthma.


Subject(s)
Administration, Inhalation , Adolescent , Androstadienes/therapeutic use , Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Bronchial Hyperreactivity/chemically induced , Bronchial Provocation Tests , Child , Female , Forced Expiratory Volume/drug effects , Humans , Male , Methacholine Chloride/adverse effects , Treatment Outcome
4.
Asian Pac J Allergy Immunol ; 1992 Dec; 10(2): 89-94
Article in English | IMSEAR | ID: sea-37016

ABSTRACT

Thirty asthmatic children, 5 to 14 years of age, 20 boys and 10 girls, were studied while having acute asthmatic attacks. Each group of 10 children received either a single dose of 6 puffs (1500 micrograms) or 3 doses of 2 puffs (500 micrograms) at 5-minute or 15-minute intervals of terbutaline pressurized aerosol inhaler through a 750-ml volumetric spacer. The onset of bronchodilatation was observed within 2 minutes in all. The 3 doses at 15-minute intervals gave the greatest bronchodilatation throughout the 6-hour study period in comparing with the other two regimens. Slightly insignificant increases in systolic blood pressure and heart rate were observed in all groups and there were no statistically significant differences among them. No serious side effects were observed.


Subject(s)
Acute Disease , Administration, Inhalation , Adolescent , Asthma/drug therapy , Blood Pressure/drug effects , Bronchi/drug effects , Bronchoconstriction/drug effects , Child , Child, Preschool , Drug Administration Schedule , Female , Heart Rate/drug effects , Humans , Male , Random Allocation , Respiratory Function Tests , Terbutaline/administration & dosage
5.
Asian Pac J Allergy Immunol ; 1990 Jun; 8(1): 45-8
Article in English | IMSEAR | ID: sea-36458

ABSTRACT

Twenty asthmatic children, aged 4 to 15 years, consisting of 14 boys and 6 girls, were studied during acute episodes of asthmatic attacks. A group of 10 children each received either inhaled terbutaline 0.5 mg or inhaled terbutaline 0.5 mg followed by ipratropium bromide 0.04 mg 15 minutes later through a 750-ml volumetric spacer. Significant increases in FEV1 over the baseline were observed from 2 minutes to 2 hours and from 2 minutes to 6 hours following the first and second regimen respectively. A slightly greater increase and longer duration in FEV1 were observed in the combined drug treatment and very slight decreases in systolic and diastolic blood pressure below the base-line were observed. Neither regimen showed any serious adverse effect on the heart rate and respiratory rate.


Subject(s)
Acute Disease , Adolescent , Asthma/drug therapy , Atropine Derivatives/therapeutic use , Blood Pressure/drug effects , Child , Child, Preschool , Drug Therapy, Combination , Female , Forced Expiratory Volume/drug effects , Heart Rate/drug effects , Humans , Ipratropium/administration & dosage , Male , Nebulizers and Vaporizers , Respiration/drug effects , Terbutaline/administration & dosage
6.
Asian Pac J Allergy Immunol ; 1989 Dec; 7(2): 113-8
Article in English | IMSEAR | ID: sea-37080

ABSTRACT

A 15-year survey of atmospheric pollen and mold spores was carried out in Bangkok, Thailand, from January 1973 to December 1987 by Durham's standard gravity slide sampler. The pollen and mold spore counts were presented. The peak of the pollen and mold spores occurred during the time of the year with lower average temperature, relative humidity and rain-fall. For pollen, this was from November to January and for mold spores from December to February. Mold spores of the Class Fungi Imperfecti were predominant and most likely the major fungi in mold allergy. Grass was the principal air-borne pollen.


Subject(s)
Air/analysis , Atmosphere , Poaceae , Pollen/analysis , Spores, Fungal , Thailand , Time Factors
7.
Asian Pac J Allergy Immunol ; 1989 Jun; 7(1): 29-32
Article in English | IMSEAR | ID: sea-37166

ABSTRACT

Thirty asthmatic children, aged 4 to 13 years, 22 boys and 8 girls, were studied during acute asthmatic attacks. Each group of 15 children received either a 0.01 mg/kg subcutaneous injection of terbutaline or 2 puffs from terbutaline pressurized aerosol (0.25 mg/puff) inhaler through a 750-ml volumetric spacer. A slightly greater increase in PEFR following injection compared with inhalation throughout the 6 hours study period was observed. Significant increases in systolic blood pressure and pulse rate were observed only after injection. Therefore, it was concluded that inhaled terbutaline is safe and effective for treating children over 4 years of age with acute bronchospasm and has less cardiovascular side effects than injected terbutaline.


Subject(s)
Acute Disease , Adolescent , Aerosols , Asthma/drug therapy , Blood Pressure/drug effects , Child , Child, Preschool , Female , Heart Rate/drug effects , Humans , Injections, Subcutaneous , Male , Peak Expiratory Flow Rate , Terbutaline/administration & dosage , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL